**Question:** All of the following increase small intestinal motility except

A. Loperamide
B. Metoclopramide
C. Domperidone
D. Alvimopan

**Correct Answer:** A. Loperamide

**Core Concept:** Small intestinal motility refers to the coordinated contractions of smooth muscles in the small intestine that propel food through the gastrointestinal tract. Drugs that increase intestinal motility are commonly used in gastroenterology to stimulate digestion, alleviate constipation, or accelerate wound healing after surgery.

**Why the Correct Answer is Right:** Loperamide is primarily an opioid receptor agonist, primarily targeting μ-opioid receptors in the gastrointestinal tract. Although it is used to manage diarrhea, it suppresses intestinal motility due to its direct effect on opioid receptors, which reduces peristalsis and increases intestinal transit time.

**Why Each Wrong Option is Incorrect:**

B. Metoclopramide: Metoclopramide is a dopamine D2 receptor antagonist, primarily used to treat nausea, vomiting, and gastroesophageal reflux disease (GERD) by stimulating gastric motility and reducing gastric emptying time.

C. Domperidone: Domperidone is a dopamine D2 receptor antagonist, similar to metoclopramide, but with a lower risk of extrapyramidal side effects due to its selective binding to D2 receptors in the gastrointestinal tract without affecting striatal dopamine levels.

D. Alvimopan: Alvimopan is a serotonin 5-HT3 receptor antagonist, specifically targeting 5-HT3 receptors in the gut to stimulate intestinal motility and reduce transit time.

**Clinical Pearl:** In clinical practice, understanding the pharmacological effects of medications on intestinal motility is crucial for selecting the appropriate treatment for various gastrointestinal disorders, ensuring a proper balance between stimulating digestion and avoiding side effects like constipation or delayed gastric emptying.